Gil Kaplan MD MPH (@gilkaplan) 's Twitter Profile
Gil Kaplan MD MPH

@gilkaplan

Gastroenterologist & epidemiologist. Professor @UCalgary. Associate Editor, @AGA_Gastro My life's work: rdcu.be/cbtoW Tweets are my personal views.

ID: 3246440719

linkhttps://wpsites.ucalgary.ca/gilkaplan/ calendar_today16-06-2015 01:20:55

1,1K Tweet

2,2K Followers

778 Following

Healio Gastroenterology (@healiogastro) 's Twitter Profile Photo

The cost 💰of #IBD care: 👉🏻Average cost per patient increased from $8,477 in 2009➡️$15,786 in 2018-2019. 👉🏻Annual cost for at least one #biologic 💊 increased while the cost of nonbiologic medications decreased. Dr. Stephanie Coward #CCCongress24 ⬇️⬇️ healio.com/news/gastroent…

Gil Kaplan MD MPH (@gilkaplan) 's Twitter Profile Photo

20 years ago, as a GI fellow at the GRIT and CDDW conference, I looked up to mentors at the podium. It’s a true privilege to return two decades later and stand at that podium to speak on the global epidemiology of IBD.

Gil Kaplan MD MPH (@gilkaplan) 's Twitter Profile Photo

I want to thank Dr. LD and Joey Windsor, PhD co-first authors of the nature paper, for their incredible work in synthesizing and analyzing a treasure trove of global epidemiologic data on IBD. Check out this amazing story from U Calgary: ucalgary.ca/news/research-…

Gil Kaplan MD MPH (@gilkaplan) 's Twitter Profile Photo

Brilliant on the podium, Dr. Stephanie Coward forecasted that in 9 Stage 3 countries, IBD incidence will reach 30 per 100,000 and prevalence 0.8% by 2025—projected to rise to 1% by 2035. A standout moment from a standout epidemiologist. #DDW2025

Brilliant on the podium, <a href="/Stephanie_Epi/">Dr. Stephanie Coward</a> forecasted that in 9 Stage 3 countries, IBD incidence will reach 30 per 100,000 and prevalence 0.8% by 2025—projected to rise to 1% by 2035. A standout moment from a standout epidemiologist. #DDW2025
Gil Kaplan MD MPH (@gilkaplan) 's Twitter Profile Photo

On the podium, Joey Windsor, PhD shared findings from our 5-year journey defining the epidemiologic stages of IBD—now published in nature. His latest work shows a narrowing UC:CD ratio across the first three stages in IBD’s evolution. Full story: nature.com/articles/s4158…

On the podium, <a href="/LingJWWindsor/">Joey Windsor, PhD</a> shared findings from our 5-year journey defining the epidemiologic stages of IBD—now published in <a href="/Nature/">nature</a>. His latest work shows a narrowing UC:CD ratio across the first three stages in IBD’s evolution. Full story: nature.com/articles/s4158…
Nature Portfolio (@natureportfolio) 's Twitter Profile Photo

An analysis in nature shows spatiotemporal transitions across epidemiologic stages 1 to 3 of inflammatory bowel disease, and models stage 4 progression. go.nature.com/42FFOtR

An analysis in <a href="/Nature/">nature</a> shows spatiotemporal transitions across epidemiologic stages 1 to 3 of inflammatory bowel disease, and models stage 4 progression. go.nature.com/42FFOtR
Snyder Institute for Chronic Diseases (@snyderinstitute) 's Twitter Profile Photo

The number of people living with IBD is expected to surge by 2045, according to a new global study published in Nature Portfolio, co-led by Dr. Gil Kaplan MD MPH. msn.com/en-in/health/o… #IBD #HealthcareCrisis #CanadaHealth #IBDCanada UCalgaryMedicine U Calgary O'Brien Institute for Public Health